Kolon TissueGene, Inc. (KOSDAQ:950160)
South Korea · Delayed Price · Currency is KRW 94,300
-5,600 (-5.61%)
At close: Feb 6, 2026
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 7.85 trillion as of February 6, 2026. Its market cap has increased by 244.89% in one year.
Market Cap
7.85T
Enterprise Value
7.81T
Revenue
5.08B
Ranking
n/a
PE Ratio
n/a
Stock Price
94,300.00
Market Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has increased from 2.58T to 7.85T, an increase of 204.39%. That is a compound annual growth rate of 14.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 7.85T | 18.47% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALTEOGEN | 19.31T |
| SK Biopharmaceuticals | 8.50T |
| HLB Co., Ltd. | 6.73T |
| LigaChem Biosciences | 6.18T |
| Peptron | 5.77T |
| SK bioscience | 3.84T |
| Voronoi | 3.68T |
| PharmaResearch | 3.53T |